Ignite Creation Date:
2024-05-06 @ 6:41 PM
Last Modification Date:
2024-10-26 @ 2:52 PM
Study NCT ID:
NCT05742217
Status:
RECRUITING
Last Update Posted:
2024-02-20
First Post:
2023-02-15
Brief Title:
A Study to Learn How Patients With Triple Class Refractory Multiple Myeloma TCR-MM Are Treated in Italian Centers for Blood Related Diseases
Sponsor:
Pfizer
Organization:
Pfizer
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-05-26
Start Date Type:
ACTUAL
Primary Completion Date:
2024-08-31
Primary Completion Date Type:
ESTIMATED
Completion Date:
2024-11-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-02-15
First Submit QC Date:
February 15 2023
Study First Post Date:
2023-02-23
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2024-02-15
Last Update Post Date:
2024-02-20
Last Update Post Date Type:
ACTUAL